Adult male rabbits were exposed to high concentrations (750 ppm, 12 hours daily for 7 days) of toluene, xylenes, styrene, ethylbenzene, vinyltoluene (3-methylstyrene), and 7-methyl-styrene vapours or were dosed with 4 mM/kg/day i.p. of hippuric, methylhippuric, mandelic, phenylglyoxylic, and 7-methyl-mandelic acids. Styrene, vinyltoluene and ethylbenzene caused a marked depletion of striatal and tuberoinfundibular dopamine. Such an effect was also caused by treatment with phenylglyoxylic and mandelic acids. Dopamine depletion was associated with an increase in homovanillic acid concentration in the same regions. These results indicate that dopamine metabolism is a target for the neurotoxic effects of some monocyclic aromatic hydrocarbons and their metabolites, a lateral vinyl- or ethyl-chain being crucial for the structure/activity relationship of such compounds.
BackgroundJoint involvement is the most frequent extra-intestinal manifestation of paediatric inflammatory bowel disease (IBD). Various recent studies focused on the clinical prevalence of enthesitis in children and adults with IBD1, and others have demonstrated the ability of ultrasound (US) to visualise the acute and chronic signs of entheseal inflammation with greater sensitivity than a clinical examination, although there is a lack of consensus concerning the US definition of entheseal abnormalities and their prognostic value especially in the paediatric field2.ObjectivesThe aim of this study was to evaluate the prevalence of subclinical entheseal involvement in patients with pediatric IBD using a high frequency ultrasound probe.MethodsTwenty-seven pediatric IBD patients (13 with Crohn's disease [CD] and 14 with ulcerative colitis [UC]; 15 females and 12 males; mean age 13.7 years, range 7-21 years) without any clinical signs or symptoms of musculo-skeletal involvement and 24 healthy age- and gender-matched controls (14 females and 13 males; mean age 14.2 years, range 8-20 years) underwent an US examination (ESAOTE MyLAB 70 6-18 MHz linear array transducer). Brachial triceps, femoral quadriceps, Achilles, plantar fascia, and proximal and distal patellar entheses were all scored using the 0-136 Madrid Sonographic Enthesis Index (MASEI). Clinical and clinimetrical variables were assessed in both groups (MASES, BASDAI, BASFI, cHAQ, PCAI/PCDAI).ResultsNone of the patients had a MASEI score suggesting early spondyloarthritis involvement but their average score was significantly higher than controls (3.15±2.84 vs 0.96±1.12, p=0.0006). There was also a significantly higher percentage of patients with at least one enthesis with power Doppler (PD) score ≥2 (37% vs 16%; p=0.037) and at least one enthesis with dishomogeneous echostructure (59% vs 0%; p=0.000). There were no between-group differences in terms of erosions (0% vs 0%), calcifications (7.4% vs 12.5%; p=0.656) or structural thickness (37% vs 33.3%; p=0.507). In paediatric IBD group we cannot find correlation between the total MASEI score and gender (p=0.12), age (p=0.20), disease duration (p=0.18) or IBD activity (p=0.83).ConclusionsUS detectable enthesopathy is frequent in paediatric IBD patients without any clinical signs or symptoms of musculo-skeletal involvement. Further studies involving a larger number of patients are needed to confirm these preliminary data.ReferencesHorton DB. et Al. Enthesitis is an Extraintestinal Manifestation of Pediatric Inflammatory Bowel Disease. Ann Paediatr Rheumatol. 2012; 10:1.0Bandinelli F, Milla M, Genise S, et al. Ultrasound discloses entheseal involvement in inactive and low active inflammatory bowel disease without clinical signs and symptoms of spondyloarthropaty. Rheumatology (Oxford) 2011; 50:1275-9Disclosure of InterestNone declared
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.